Mechanistically, miR-192 contributes to kidney disease by forming a TGF-β-induced positive feedback loop with p53, suppressing Zeb2, and promoting kidney fibrosis, while its inhibition or deletion reduces these pathological features [38]. Here, TGFB1 is linked to kidney disorder.